| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +237K | 86% | $0.12 | +$29.3K |
| Sells | 1 | -38.5K | 14% | $0.06 | -$2.29K |
| Net | 0 | +199K | 72.1% | +$27K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Seah H. Lim | Director | $614K | -$2.29K | -0.37% | Sep 16, 2024 |
| Wei Peu ZEN | Director | $317K | Feb 1, 2024 | ||
| Willis C. Lee | Co-President & COO, Director | $133K | +$29.3K | +28.2% | Feb 26, 2024 |
| Charles W. Stark | CSO & EVP Clinical Development | $30K | Feb 1, 2024 | ||
| Yasushi Nagasaki | Cfo | $30K | Feb 1, 2024 | ||
| George Sekulich | Co-President & CCO, Director | $30K | Feb 1, 2024 | ||
| Ian Zwicker | Director | $15K | Feb 1, 2024 | ||
| Alfred Lui | Director | $2.12K | Jan 3, 2022 | ||
| Lori Teranishi | Director | $908 | Jan 6, 2022 | ||
| Yutaka Niihara | Chairman and CEO, Director, 10%+ Owner | Jan 12, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|